February 2023
KDIGO Hosts Women and Kidney Health Controversies Conference
This month, KDIGO held the Women and Kidney Health Controversies Conference in Athens, Greece, co-chaired by Giorgina Piccoli, MD (Italy-France), and Christina Wyatt, MD (United States). A global panel of individuals with multidisciplinary clinical and scientific expertise, including nephrology, obstetrics, pediatrics, neonatology, midwifery, and dietetics convened to identify key gender and sex issues in kidney care. The conference included patients with experience of preeclampsia and with kidney disease, on dialysis, and who have received a kidney transplant. Over thirty countries were represented.
The conference endeavored to describe current best practices, identify areas of uncertainty, address ongoing controversial issues, and outline research needed to move the field forward. The conference format involved topical plenary session presentations, followed by focused discussion groups that reported on their areas to all attendees for consensus building.
“This conference had a broad scope and wide range of topics to be addressed in only three days, and everyone came prepared for the challenge,” said Dr. Wyatt. “The discussions and debates were as robust as they were productive, with outstanding contributions from both clinicians and patients.”
Several themes and ideas emerged during the conference, including improving access to basic primary healthcare, customizing care to specific patient needs, and leveraging current data to inform gender-based treatment of kidney disease. A patient panel highlighted the importance of individualized care, particularly concerning reproductive issues and pregnancy in women with kidney disease. Attendees addressed how existing databases like electronic medical records could be used to better understand the epidemiology and burden of kidney disease in females and women. Biomarker data was also widely discussed, and in particular, how data can be used to gain insights into the risk of pre-eclampsia and on differential diagnosis with kidney diseases.
“This conference was a dream made true for many of us,” said Dr. Piccoli. “We could not have asked for a better, more enthusiastic, and committed group of experts and patients to identify and address how to improve care and outcomes for women with kidney disease.”
KDIGO Releases Methods Manual for Guideline Development
KDIGO has released its Methods Manual for Guideline Development, which provides a comprehensive overview of the processes and evidence review methods that serve as the basis for developing and updating KDIGO Guidelines.
The manual was developed by the KDIGO Methods Committee, led by Marcello Tonelli, MD (Canada), and KDIGO Guideline Development Director, Amy Earley (United States), to explain the process of KDIGO guideline development from topic prioritization to publication. Graphics and links throughout the Methods Manual offer examples and support descriptions of often complex processes.

The manual is not intended as a handbook for conducting a systematic review or developing independent guidelines, but rather defines and explains each step in these KDIGO processes. This includes, but is not limited to topic selection, appointment of guideline co-chairs and work group members, disclosures of interest, scope of work development, selecting an evidence review team, evidence review steps, format for writing guidelines, public review of the draft guideline, publication, implementation, and guideline updates. 
“KDIGO Guidelines have a global impact on how clinicians treat patients with kidney disease. The Methods Manual will help clinicians and researchers to better understand the processes and requirements behind KDIGO guidelines and recommendations,” said Dr. Tonelli. “We hope this document offers a transparent summary of how KDIGO develops its guidelines and clearly shows that recommendations from KDIGO Guidelines are based on credible, rigorous systematic reviews that summarize all the relevant evidence.”
“KDIGO is deeply grateful to the Methods Committee, and in particular, to Dr. Tonelli, for this immensely valuable and important document,” said KDIGO Chief Executive Officer, John Davis. “In addition to chairing our Methods Committee, Dr. Tonelli is co-chairing the KDIGO Anemia Guideline Update and is currently a candidate for president of the ISN. Volunteers are the driving force in KDIGO, and we are fortunate to work with such able and committed experts from around the world."
The Methods Manual is available on the KDIGO website.
Upcoming Events & Webinars
African Nephrology & Transplantation Summit 2023
February 14-18, Cairo, Egypt

Don't miss the African Nephrology & Transplantation Summit, from February 14-18 in Cairo, Egypt. The program will be available both in person and online.

The summit includes a KDIGO session on Thursday, February 16, from 10:15 am-11:15 am (Cairo Time). The session features: Hani Hafez (Egypt), president of the Egyptian Society, congress president for AFRAN Cairo and next president of AFRAN; a talk from KDIGO Co-Chair, Michel Jadoul (Belgium), on the 2022 KDIGO Chronic Kidney Disease (CKD) Controversies Conference and perspectives for the upcoming CKD Guideline Update; and a talk on the KDIGO Glomerular Diseases Guideline from Vivekanand Jha (India), workgroup member and past-president of the ISN. Learn more and register.
KDIGO-PlatformQ Health Webinar: KDIGO - New Directions about FSGS Treatment and Why They Matter to Me
Live on Thursday, February 16 at 2:00 p.m. ET

Register now to watch live or on-demand later. During the presentation, there will be live Q & A. Send your questions to be answered during the live session by clicking here.
ISN-KDIGO Webinar: Hepatitis C Guideline Update
February 21, 6:00 p.m. CET/ 12:00 p.m. ET

Join us for the next ISN-KDIGO Webinar on the KDIGO Hepatitis C Guideline Update, on Tuesday, February 21, at 6:00 p.m. CET (12:00 p.m. ET.

The webinar will be moderated by Annette Bruchfeld, MD (Sweden), and features KDIGO Hepatitis C Guideline C0-Chairs, Paul Martin, MD (United Kingdom), and Michel Jadoul, MD (Belgium). The webinar will address expanded treatment options with newer direct-acting antiviral agents (DAAs) for hepatitis C infection in patients with all stages of chronic kidney disease. Attendees will learn how the availability of DAA therapy allows the use of hepatitis C-infected donors in kidney transplantation. The webinar will also incorporate advances in hepatitis C treatment in the management of glomerulonephritis, including indications for kidney biopsy. Learn more and register.
KDIGO-PlatformQ Health Webinar: Reducing Risk of Transplantation for People with IgA Nephropathy: What Managed Care Pharmacists Can Do to Help Optimize Treatment
Live on Tuesday, February 21, from 9:00 a.m. – 10:00 a.m. ET

Register for a new KDIGO-PlatformQ Health program, "Reducing Risk of Transplantation for People with IgA Nephropathy (IgAN): What Managed Care Pharmacists Can Do to Help Optimize Treatment," with Rosanna Coppo, MD (Italy), and Michelle Richardson, PharmD (United States). Join an expert nephrologist and pharmacist to discuss these new and emerging treatment options, up-to-date evidence on their safety and efficacy, and recommendations from practice guidelines. Managed care pharmacists will be prepared to enhance access to these beneficial treatments and include them in medication-management programs for appropriate patients with IgAN. Register.
e-SPACE Cardio-Renal-Metabolic (CRM) 2023
March 24 - 25, Virtual

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to introduce e-SPACE CRM 2023 to be held March 24 - 25.

This year's e-SPACE CRM will deliver best-in-class, free-to-access virtual education. Bringing together thought leaders from across the globe, e-SPACE CRM 2023 will optimize geographical reach while delivering both global and regional insight. A thoughtfully curated program will support the exploration of how leading experts, in cardiology, nephrology, and diabetology, are treating interrelated diseases. Learn more and register.
New Resources
Annals of Internal Medicine: Synopsis of the KDIGO 2022 Diabetes in CKD Guideline

Annals of Internal Medicine has released its synopsis of the KDIGO 2022 Diabetes in CKD Guideline. Read the synopsis and check out additional resources on the KDIGO Diabetes in CKD Guideline Website.
Guidelines Summary for Primary Care: Summary of the KDIGO 2022 Diabetes in CKD Guideline

Guidelines for Primary Care (UK) has released a summary of the KDIGO 2022 Diabetes in CKD Guideline. Read the summary and check out additional resources on the KDIGO Diabetes in CKD Guideline Website.

The KDIGO 2022 Diabetes in CKD Guideline Top 10 Takeaways are now available in German.

Read the translation and check out additional resources on the KDIGO Diabetes in CKD Guideline Website.
Clinical Series Live Program: Explore a Novel Approach to the Treatment of IgA Nephropathy

Check out a ClinicalSeriesLive program to explore a novel approach to the treatment of IgA Nephropathy. Register.

KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve patient outcomes on a global basis. KDIGO is independent, volunteer-led, self-managed, and accountable to the public and the patients it serves. Learn More.